US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
NZ511762A
(en)
|
1993-07-19 |
2003-09-26 |
Univ British Columbia |
Anti-angiogenic compositions and methods of use
|
ES2151277T3
(en)
*
|
1996-05-22 |
2000-12-16 |
Protarga Inc |
COMPOSITIONS INCLUDING CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE.
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
EP0868422A1
(en)
*
|
1996-09-24 |
1998-10-07 |
Marigen S.A. |
Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
US6649632B2
(en)
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
US20030054036A1
(en)
|
2001-03-13 |
2003-03-20 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
DK1392254T3
(en)
|
2001-04-20 |
2007-07-02 |
Univ British Columbia |
Micelle drug delivery system for hydrophobic drugs
|
CA2354471A1
(en)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
C10 ester substituted taxanes
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
WO2004060346A2
(en)
|
2002-12-30 |
2004-07-22 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US20070172446A1
(en)
|
2003-05-16 |
2007-07-26 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
HN2005000054A
(en)
|
2004-02-13 |
2009-02-18 |
Florida State University Foundation Inc |
REPLACED TAXANS WITH CYCLOPENTILO ESTERS IN C10
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US8691780B2
(en)
|
2005-02-17 |
2014-04-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
AU2007228984B2
(en)
|
2006-03-22 |
2012-05-03 |
Syncore Biotechnology Co., Ltd |
Treatment of triple receptor negative breast cancer
|
EP2043704B2
(en)
|
2006-06-30 |
2017-04-19 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8242166B2
(en)
|
2008-03-31 |
2012-08-14 |
Florida State University Research Foundation, Inc. |
C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
WO2009143454A2
(en)
|
2008-05-22 |
2009-11-26 |
Kereos, Inc. |
Combination antitumor therapy
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
CN104582717B
(en)
|
2012-07-19 |
2018-03-13 |
雷德伍德生物科技股份有限公司 |
There are specific antibody and its application method to CD22
|
WO2014074218A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
EP3881868B1
(en)
|
2013-02-15 |
2023-09-27 |
The Regents Of The University Of California |
Chimeric antigen receptor and methods of use thereof
|
KR20150135332A
(en)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
CA2927806C
(en)
|
2013-11-27 |
2023-01-10 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
DK3107899T3
(en)
|
2014-02-19 |
2020-11-16 |
Aviv Therapeutics Inc |
MITOCONDRIAL ALDEHYDE HYDROGENASE 2 (ALDH2) -BINDING POLYCYCLIC AMIDES AND ITS USE FOR CANCER TREATMENT
|
KR20180058759A
(en)
|
2015-09-25 |
2018-06-01 |
제트와이 테라퓨틱스 인코포레이티드 |
Pharmaceutical preparations based on microparticles comprising a polysaccharide-vitamin conjugate
|
WO2017083637A1
(en)
|
2015-11-12 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
TWI760319B
(en)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
Treatment of breast cancer
|
WO2017189432A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
KR102473887B1
(en)
|
2016-06-01 |
2022-12-06 |
세르비에 아이피 유케이 리미티드 |
Formulations of polyalkylene oxide-asparaginase, and methods of making and using the same
|
TW201825087A
(en)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
Treatment of pancreatic cancer
|
KR20190130559A
(en)
|
2017-01-18 |
2019-11-22 |
에프1 온콜로지, 인코포레이티드 |
Chimeric Antigen Receptors for AXL or ROR2 and Methods of Use thereof
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
CN111902147A
(en)
|
2018-01-31 |
2020-11-06 |
加莱拉实验室有限责任公司 |
Combination cancer therapy of pentaazamacrocycle complexes and platinum-based anticancer agents
|
BR112020020930A2
(en)
|
2018-04-11 |
2021-03-02 |
Ohio State Innovation Foundation |
drug delivery composition, method for treating an eye disorder and kit
|
US11897928B2
(en)
|
2018-07-18 |
2024-02-13 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
TW202038994A
(en)
|
2019-01-14 |
2020-11-01 |
美商醫格耐免疫治療公司 |
Recombinant vaccinia virus and methods of use thereof
|
JP2022520220A
(en)
|
2019-02-14 |
2022-03-29 |
イグナイト イミュノセラピー インク |
Recombinant vaccinia virus and how to use it
|
CN113692413A
(en)
|
2019-04-02 |
2021-11-23 |
肯乔克蒂生物技术股份有限公司 |
Efflux pump-cancer antigen multispecific antibodies and compositions, reagents, kits and methods related thereto
|
JP2021106576A
(en)
|
2019-12-12 |
2021-07-29 |
イグナイト・イミュノセラピー,インコーポレーテッド |
Variant oncolytic vaccinia virus and methods of use thereof
|
US20230203156A1
(en)
|
2020-01-29 |
2023-06-29 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
AU2021284240A1
(en)
|
2020-06-04 |
2022-12-08 |
Kenjockety Biotechnology, Inc. |
Anti-ABCG2 antibodies and uses thereof
|
WO2021247423A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
EP4182335A2
(en)
|
2020-07-14 |
2023-05-24 |
Pfizer Inc. |
Recombinant vaccinia virus
|
JP2023539883A
(en)
|
2020-09-02 |
2023-09-20 |
ケンジョッケティ バイオテクノロジー,インク. |
Anti-ABCC1 antibody and its use
|
AU2021380659A1
(en)
|
2020-11-13 |
2023-06-01 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
CA3238353A1
(en)
|
2021-12-13 |
2023-06-22 |
William Robert ARATHOON |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|